NUVB Nuvation Bio Inc

Price (delayed)

$3.13

Market cap

$773.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.32

Enterprise value

$742.67M

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and ...

Highlights
The net income has increased by 34% year-on-year and by 9% since the previous quarter
NUVB's EPS is up by 32% YoY and by 9% QoQ
The company's quick ratio fell by 26% YoY and by 13% QoQ
NUVB's equity is down by 7% year-on-year

Key stats

What are the main financial stats of NUVB
Market
Shares outstanding
247.17M
Market cap
$773.64M
Enterprise value
$742.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$68.87M
EBITDA
-$68.73M
Free cash flow
-$64.44M
Per share
EPS
-$0.32
Free cash flow per share
-$0.29
Book value per share
$2.71
Revenue per share
$0
TBVPS
$2.8
Balance sheet
Total assets
$613.13M
Total liabilities
$19.08M
Debt
$3.53M
Equity
$594.04M
Working capital
$592.29M
Liquidity
Debt to equity
0.01
Current ratio
38.58
Quick ratio
37.87
Net debt/EBITDA
0.45
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-11%
Return on equity
-11.3%
Return on invested capital
-11.9%
Return on capital employed
-11.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVB stock price

How has the Nuvation Bio stock price performed over time
Intraday
4.33%
1 week
-9.01%
1 month
2.62%
1 year
63.87%
YTD
107.28%
QTD
7.19%

Financial performance

How have Nuvation Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$93.5M
Net income
-$68.87M
Gross margin
N/A
Net margin
N/A
The net income has increased by 34% year-on-year and by 9% since the previous quarter
The operating income rose by 21% year-on-year and by 6% since the previous quarter

Growth

What is Nuvation Bio's growth rate over time

Valuation

What is Nuvation Bio stock price valuation
P/E
N/A
P/B
1.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NUVB's EPS is up by 32% YoY and by 9% QoQ
The stock's price to book (P/B) is 44% more than its last 4 quarters average of 0.8
NUVB's equity is down by 7% year-on-year

Efficiency

How efficient is Nuvation Bio business performance
The return on invested capital has increased by 34% year-on-year and by 7% since the previous quarter
NUVB's ROE is up by 28% YoY and by 7% from the previous quarter
NUVB's return on assets is up by 28% year-on-year and by 8% since the previous quarter

Dividends

What is NUVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVB.

Financial health

How did Nuvation Bio financials performed over time
The current ratio fell by 26% YoY and by 13% QoQ
The company's quick ratio fell by 26% YoY and by 13% QoQ
Nuvation Bio's debt is 99% lower than its equity
Nuvation Bio's debt has decreased by 12% QoQ and by 11% YoY
NUVB's equity is down by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.